Edesa Biotech, Inc. (EDSA) delivered a return of 203.76% over the past year. Since EDSA does not currently pay dividends, the total return equals the price-only return.

A $10,000 investment in Edesa Biotech, Inc. one year ago would be worth $30,376 today, representing a gain of $20,376.

Edesa Biotech, Inc. (EDSA) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For EDSA, the total return equals the price-only return.

Yes, Edesa Biotech, Inc. (EDSA) outperformed the S&P 500 by 181.08 percentage points over the past year. EDSA delivered a total return of 203.76%, compared to the S&P 500's 22.68%. This 181.08pp alpha means investors in EDSA earned more than a passive S&P 500 index fund.

Edesa Biotech, Inc. (EDSA) experienced a maximum drawdown of -72.22% over the past year, declining from its peak on 2026-04-30 to its trough on 2026-06-09. The stock has not yet fully recovered to its prior peak. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Here are Edesa Biotech, Inc. (EDSA)'s long-term returns with dividends reinvested. Over 10 years, the total return is -99.3% (-39.0% CAGR) — $10,000 would have grown to $71. Over 20 years: -99.0% total return (-20.7% CAGR) — $10,000 → $96. Over 30 years: -99.0% total return (-14.3% CAGR) — $10,000 → $96. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Edesa Biotech, Inc.'s best calendar year was 2010 with a total return of 615.0%. Its worst year was 2018 with a total return of -84.7%. This range shows the volatility investors should expect — the difference between the best and worst year is 699.7 percentage points.